Manuela Raffatellu is a full Professor at the University of California, San Diego School of Medicine. She received her M.D. at the University of Sassari, Italy, in 2000. She moved to the US in 2002, where she trained as a postdoctoral fellow at Texas A&M University and at the University of California, Davis. She opened her laboratory as an Assistant Professor at the University of California, Irvine in 2008, where she was promoted to Associate Professor with tenure in 2014. In 2017, she was recruited as a full Professor with tenure at the University of California, San Diego.
Her research focuses on the interactions between bacterial pathogens and the immune response in the gut. Her recent efforts aim to design new strategies to reduce colonization of pathogens without affecting the beneficial microbes that inhabit our body. She has published 66 peer-reviewed articles, several of which in high-profile journals, including Nature, Nature Medicine, Immunity, Cell Host and Microbe, and PNAS, and she is a co-inventor on a patent. She has been continuously funded by the National Institutes of Health and other funding agencies since 2009. She has been invited to lecture on her research all over the world, at more than 50 academic institutions and 50 conferences. She serves as an Editor for Infection and Immunity, a journal of the American Society for Microbiology, and she is a member of a study section that reviews grant proposals for the National Institutes of Health. She is the recipient of several awards, including the IDSA ERF/NFID Astellas Young Investigator Award, the ICAAC Young Investigator Award, and the Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award. In 2014, she received the Special Prize “Candeliere d’oro” from the City of Sassari, in recognition of her scientific accomplishments.